These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1312786)
1. Effects of D-beta-hydroxybutyrate and long- and medium-chain triglycerides on leucine metabolism in humans. Beaufrère B; Chassard D; Broussolle C; Riou JP; Beylot M Am J Physiol; 1992 Mar; 262(3 Pt 1):E268-74. PubMed ID: 1312786 [TBL] [Abstract][Full Text] [Related]
2. Effects of different lipid substrates on glucose metabolism in normal postabsorptive humans. Broussolle C; Beylot M; Chassard D; Beaufrère B Metabolism; 1992 Dec; 41(12):1276-83. PubMed ID: 1461133 [TBL] [Abstract][Full Text] [Related]
3. Effects of medium- and long-chain fatty acids on whole body leucine and glucose kinetics in man. Keller U; Turkalj I; Laager R; Bloesch D; Bilz S Metabolism; 2002 Jun; 51(6):754-60. PubMed ID: 12037730 [TBL] [Abstract][Full Text] [Related]
4. Failure of infused beta-hydroxybutyrate to decrease proteolysis in man. Miles JM; Nissen SL; Rizza RA; Gerich JE; Haymond MW Diabetes; 1983 Mar; 32(3):197-205. PubMed ID: 6298041 [TBL] [Abstract][Full Text] [Related]
5. Odd-numbered medium-chain triglycerides (trinonanoin) in total parenteral nutrition: effects on parameters of fat metabolism in rabbits. Linseisen J; Wolfram G JPEN J Parenter Enteral Nutr; 1993; 17(6):522-8. PubMed ID: 8301805 [TBL] [Abstract][Full Text] [Related]
6. Infusion of long-chain or medium-chain triglycerides inhibits peripheral glucose metabolism in men. Stouthard JM; Endert E; Romijn JA; Sauerwein HP JPEN J Parenter Enteral Nutr; 1994; 18(5):436-41. PubMed ID: 7815676 [TBL] [Abstract][Full Text] [Related]
7. Leucine metabolism in preterm infants receiving parenteral nutrition with medium-chain compared with long-chain triacylglycerol emulsions. Liet JM; Piloquet H; Marchini JS; Maugère P; Bobin C; Rozé JC; Darmaun D Am J Clin Nutr; 1999 Mar; 69(3):539-43. PubMed ID: 10075342 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of muscular ketone extraction by lipid infusion in man. Rett K; Wicklmayr M; Baldermann H; Dietze G; Schwiegelshohn B; Mehnert H Horm Metab Res; 1988 Aug; 20(8):502-5. PubMed ID: 3181868 [TBL] [Abstract][Full Text] [Related]
9. Apparent decreased oxidation and turnover of leucine during infusion of medium-chain triglycerides. Beaufrere B; Tessari P; Cattalini M; Miles J; Haymond MW Am J Physiol; 1985 Aug; 249(2 Pt 1):E175-82. PubMed ID: 3895976 [TBL] [Abstract][Full Text] [Related]
10. Effect of DL-3-hydroxybutyrate infusions on leucine and glucose kinetics in burned rats receiving TPN. Maiz A; Moldawer LL; Bistrian BR; Yamazaki K; Mok KT; Blackburn GL J Nutr; 1986 Jan; 116(1):149-56. PubMed ID: 3080557 [TBL] [Abstract][Full Text] [Related]
11. Influence of beta-hydroxybutyrate infusion on glucose and free fatty acid metabolism in dogs. Shaw JH; Wolfe RR Am J Physiol; 1984 Dec; 247(6 Pt 1):E756-64. PubMed ID: 6095672 [TBL] [Abstract][Full Text] [Related]
12. Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. Tessari P; Nissen SL; Miles JM; Haymond MW J Clin Invest; 1986 Feb; 77(2):575-81. PubMed ID: 3080479 [TBL] [Abstract][Full Text] [Related]
13. Effect of beta-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans. Nair KS; Welle SL; Halliday D; Campbell RG J Clin Invest; 1988 Jul; 82(1):198-205. PubMed ID: 3392207 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans. Laager R; Ninnis R; Keller U J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642 [TBL] [Abstract][Full Text] [Related]
15. Effects of acute metabolic acidosis and alkalosis on leucine metabolism in conscious dogs. Rodriguez NR; Miles JM; Schwenk WF; Haymond MW Diabetes; 1989 Jul; 38(7):847-53. PubMed ID: 2544471 [TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of a D-beta-hydroxybutyrate infusion in septic patients: inhibition of lipolysis and glucose production but not leucine oxidation. Beylot M; Chassard D; Chambrier C; Guiraud M; Odeon M; Beaufrère B; Bouletreau P Crit Care Med; 1994 Jul; 22(7):1091-8. PubMed ID: 8026196 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic studies of a new 20% fat emulsion containing 70% medium-chain triglycerides]. Puchstein C; Pfisterer M; Lessire H; Mertes N; Zander J; Kleine R; Winde G Anasth Intensivther Notfallmed; 1990 Feb; 25(1):87-92. PubMed ID: 2309996 [TBL] [Abstract][Full Text] [Related]
18. Metabolic clearance of a fat emulsion containing medium-chain triglycerides in cirrhotic patients. Fan ST; Wong J JPEN J Parenter Enteral Nutr; 1992; 16(3):279-83. PubMed ID: 1501361 [TBL] [Abstract][Full Text] [Related]
19. Intravenous infusion of a medium-chain triglyceride-enriched lipid emulsion. Weissman C; Chiolero R; Askanazi J; Gil KM; Elwyn D; Kinney JM Crit Care Med; 1988 Dec; 16(12):1183-90. PubMed ID: 3056652 [TBL] [Abstract][Full Text] [Related]
20. Thermic effect of medium-chain and long-chain triglycerides in man. Seaton TB; Welle SL; Warenko MK; Campbell RG Am J Clin Nutr; 1986 Nov; 44(5):630-4. PubMed ID: 3532757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]